ICON to Acquire Aptiv Solutions
ICON announced its intention to acquire Aptiv Solutions
ICON announced its intention to acquire Aptiv Solutions, a Reston, Va.-based services organization with operations in 16 countries. According to a press release, ICON views Aptiv's strengths in the design and execution of adaptive clinical trials through its ADDPLAN software a strength for its clients. Aptiv also owns a full-service, oncology-focused CRO in Japan, which will be combined with ICON's current operations in Tokyo and Osaka.
Read the full release here.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
FDA Grants Priority Review to Merck’s sBLA for Winrevair After Early Success in ZENITH PAH Trial
July 2nd 2025Merck’s bid to update Winrevair’s label advances with FDA priority review, backed by Phase III ZENITH data showing a 76% reduction in major morbidity and mortality events in patients with pulmonary arterial hypertension.
